
Investornewsbreaks Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Secures U.S. Patent For CYB004 Anxiety Treatment ...
(MENAFN- Investor Brand Network) Cybin (NYSE American: CYBN) (NEO: CYBN) a clinical-stage neuropsychiatry company focused on next-generation mental health therapies, announced the issuance of U.S. patent 12,318,477 supporting its CYB004 program, a …